Imara

Small molecules to treat rare blood diseases such as sickle cell disease

placeCambridge, Massachusetts, United States calendar_todayFounded 2016 groups41 employees language imaratx.com

Registered entities

Investor mix

9 investors on record; lead investors include Arix Bioscience, New Enterprise Associates, Orbimed, Lundbeck Foundation; 2 have since exited.

Investor typeCountShare
Venture capital667%
Private equity111%
Other / undisclosed222%
Coming soon